Irish team bus in Rome #ITAvIRE

I’m just going home 🏡 and

Mmm Po pppppppppppppp

Jane he’ll https://t.co/mcyObQeMC6 Thhhuiiiij

Usual Shite atmosphere in the Aviva. #IREvJPN

It’s easier to let the fraudsters keep your €99.90 than deal with @talktoBOI on the phone or form fill. Premier banking me hole!

Bang of MUFC in the commentary. “This is Armenia, this is Armenia” #ARMIRL

💙 Hope is on the horizon. Meet Dr. Alicia Lieberman MD, MS our rheumatologist at @RoswellPark, who is leading the way in using cellular therapy to fight—and one day eradicate—autoimmune diseases. For patients living with autoimmune disease, this work represents more than

Honored to be part of the #VEXAS guidelines !!! Kudos to the group!@aamdsif @MDSFoundation

Researchers led by Dr. Marcin Wlodarski (@marrowgenes) reveal unique age-dependent patterns of myelodysplastic syndrome evolution and establish novel genotype-phenotype correlations with implications for clinical surveillance. 🩺 https://t.co/d2okxsYx32

😱Challenges in hematology😱 Chronic graft-versus-host disease (GVHD) A short 🧵on what it is and how to treat

Excited to see our NHLBI work on infections and immunodeficiency in patients with #telomere biology disorders now published in @BloodPortfolio. >1/3 had significant infection history and nearly 1/2 t-lymphopenia. @FernandoCatto & @fergutierrezro1. https://t.co/FJzZqQCAVY

Ross has to start next week. Sam off the tee, simply not good enough. #LEIvGLA

Efficacy of erythroid-stimulating agent and luspatercept in VEXAS syndrome: A multicenter retrospective study by the FRENVEX group https://t.co/KGXg2GGqez

Excited to share our @nih_nhlbi group’s latest work, led by post-doc Hiroki Mizumaki, looking at the role of the adaptive and innate immune system in #VEXAS in @NatureComms. https://t.co/QQgdt31MNp @bhavishap29 @fergutierrezro1 @NealSYoung1

Congrats to FRENVEX for their study on azacitadine in #VEXAS led by @thibault_comont in @BloodJournal. Confirmed inflammatory & hematologic responses in >50%. Molecular responses in >2/3rds! Toxicity common especially in first 3 cycles. https://t.co/6fRgw3ynnb @mekinian2

“You told me to try Ozempic for weight loss! Look at me, FFS!

#RMAARS Jaysus how long did that VAR take?20 blokes fall over the line in rugby, sorted in 2 minutes 🤦🏻‍♂️

Unfortunately was not able to travel to @TheEBMT but our poster can still be viewed virtually! We report on the first 7 #VEXAS patients who underwent allo-HCT on our prospective phase II trial. High rates of #GVHD and other inflammatory complications noted. @bhavishap29

“How many teams in the Top 14 Bernard”? Top class #Jamieheaslip #FRASCO

https://t.co/Y2mMX7RITm